A first-in-human clinical trial will launch in the coming months to test GTB-5550, an immune therapy from GT Biopharma that’s designed to treat various types…
Pancreatic cancer is a rare form of cancer that begins in the pancreas, an essential organ involved in digestion and blood sugar control, but can spread, or metastasize, to other parts of the body. The disease can cause symptoms such as abdominal pain, nausea, fatigue, and jaundice, or a yellowing of the skin and eyes. However, diagnosing pancreatic cancer is difficult because most of its symptoms are unspecific and don’t become evident until the disease has already advanced significantly.
Treatment for pancreatic cancer, a rare cancer that arises from cells in the pancreas, may involve a variety of different approaches, depending on factors such as the stage of disease and a person’s health status. Due to the aggressive nature of the disease, pancreatic cancer survival rates are relatively low. An early diagnosis, when the cancer can still be treated with potentially curative surgery, is critical to improve a person’s pancreatic cancer prognosis. When surgery is not an option, chemotherapy, radiation, and other supportive care measures may help control the cancer and keep patients comfortable for as long as possible.
PANCREATIC CANCER
A first-in-human clinical trial will launch in the coming months to test GTB-5550, an immune therapy from GT Biopharma that’s designed to treat various types…
PANCREATIC CANCER
A first-in-human clinical trial testing RMC-5127, an experimental treatment for people with pancreatic cancer and other cancers marked by a specific genetic mutation called…
PANCREATIC CANCER
After a year of treatment with the experimental medication atebimetinib as an add-on to chemotherapy, about two-thirds of pancreatic cancer patients in an ongoing…
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to NP-G2-044, an experimental treatment for pancreatic cancer that’s currently in clinical…
PANCREATIC CANCER
A new experimental treatment for pancreatic cancer, ARB1002, has been granted an orphan drug designation by the U.S. Food and Drug Administration (FDA) and…
A new Phase 3 clinical trial has officially begun dosing patients to see if an experimental oral therapy can prevent the recurrence of pancreatic cancer…
Don't have an account?
|
Already have an account?
Create your account by filling in the information below:
By creating an account, you are agreeing to the Privacy Policy and Terms of Service.